Spero Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Spero Therapeutics (SPRO) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Spero Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Spero Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Spero Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $51k | 27k | 1.88 |
| 2025-06-30 | $24k | 8.2k | 2.90 |
| 2025-03-31 | $2.0k | 2.8k | 0.72 |
| 2024-12-31 | $145 | 141 | 1.03 |
| 2024-09-30 | $24k | 18k | 1.34 |
| 2024-06-30 | $430 | 331 | 1.30 |
| 2024-03-31 | $9.9k | 5.7k | 1.72 |
| 2023-12-31 | $483 | 329 | 1.47 |
| 2023-09-30 | $33k | 27k | 1.20 |
| 2023-06-30 | $39k | 27k | 1.45 |
| 2023-03-31 | $60k | 42k | 1.45 |
| 2022-12-31 | $79k | 46k | 1.73 |
| 2022-09-30 | $46k | 23k | 2.00 |
| 2022-06-30 | $999 | 755 | 1.32 |
| 2022-03-31 | $7.0k | 755 | 9.27 |
| 2021-12-31 | $520k | 33k | 15.71 |
| 2021-09-30 | $530k | 29k | 18.39 |
| 2021-06-30 | $27k | 1.9k | 14.29 |
| 2021-03-31 | $456k | 31k | 14.71 |
| 2020-12-31 | $277k | 14k | 19.33 |
| 2020-09-30 | $6.0k | 500 | 12.00 |
| 2020-06-30 | $79k | 6.0k | 13.33 |
| 2020-03-31 | $73k | 9.0k | 8.14 |
| 2019-12-31 | $137k | 14k | 9.60 |
| 2019-09-30 | $117k | 11k | 10.59 |
| 2019-06-30 | $136k | 12k | 11.52 |
| 2018-12-31 | $20k | 3.2k | 6.25 |
| 2018-09-30 | $25k | 2.4k | 10.60 |
| 2018-06-30 | $13k | 945 | 14.20 |
| 2018-03-31 | $5.0k | 496 | 10.00 |
| 2017-12-31 | $0 | 128 | 0.00 |